Effect of combined Allium canadanse and Malva sylvestis in Comparison with tamsulosin in urinary stones

Comparison effect of combined Malva sylvestis and leaf of Allium canadanse with tamsulosin on pain improvement and passage of ureteral stones less than 10 millimeters in patients older than 18 years old

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20081011001323N22

Enrollment

Registered

2019-05-01

Start date

2019-04-21

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ureteral stones. Calculus of ureter

Interventions

Intervention 1: Intervention group: combined Malva sylvestis and leaf of Allium canadanse is produced in form of capsule and is consumed at a dose of 10 mg / kg / day (divided in two doses) after meal

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age more than18 years old Suffering from ureteral stone less than 10 millimeter Having informed consent form

Exclusion criteria

Exclusion criteria: Uncontrolled coagulopathy Azotemia Pregnancy Presence of active urinary tract infection Allergy to medical or herbal drugs Suffering from cardiovascular or pulmonary disease Suffering from hepatic disease

Design outcomes

Primary

Measure	Time frame
Passage of ureteral stones with sizes from 4 to 10 millimeters. Timepoint: Two weeks and one month after start of treatment. Method of measurement: Perform KUB and sonography and patient report.	—

Secondary

Measure	Time frame
The severity of pain due to stone passage. Timepoint: During the study , two weeks and one month after starting treatment. Method of measurement: With Visual Analogue Scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYasouj University of Medical Sciences

Yasouj University of Medical Sciences

dr.mehrabi@yums.ac.ir+98 33346070

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026